137 related articles for article (PubMed ID: 8554302)
1. Systematics of beta-lactams: chemical properties and structure activity relationship of oral cephalosporins.
Kees F; Grobecker H
Antibiot Chemother (1971); 1995; 47():1-7. PubMed ID: 8554302
[No Abstract] [Full Text] [Related]
2. Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins.
Negi S; Yamanaka M; Sugiyama I; Komatsu Y; Sasho M; Tsuruoka A; Kamada A; Tsukada I; Hiruma R; Katsu K
J Antibiot (Tokyo); 1994 Dec; 47(12):1507-25. PubMed ID: 7844045
[TBL] [Abstract][Full Text] [Related]
3. Studies on orally active cephalosporins. II. Synthesis and structure-activity relations of new [(E) or (Z) 3-substituted carbamoyloxy]-1-propenyl cephalosporins.
Negi S; Sasho M; Yamanaka M; Sugiyama I; Komatsu Y; Tsuruoka A; Kamada A; Tsukada I; Hiruma R; Katsu K
J Antibiot (Tokyo); 1994 Dec; 47(12):1526-40. PubMed ID: 7844046
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of oral cephalosporins.
Stoeckel K; Hayton WL; Edwards DJ
Antibiot Chemother (1971); 1995; 47():34-71. PubMed ID: 8554307
[No Abstract] [Full Text] [Related]
5. [A new oral cephem, cefdinir: its structure-activity relationships and biological profile].
Sakane K; Inamoto Y; Takaya T
Jpn J Antibiot; 1992 Aug; 45(8):909-25. PubMed ID: 1433897
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of some monocyclic- and bicyclic beta-lactams with specified functional groups.
Hwu JR; Ethiraj KS; Hakimelahi GH
Mini Rev Med Chem; 2003 Jun; 3(4):305-13. PubMed ID: 12678824
[TBL] [Abstract][Full Text] [Related]
7. [Oral cephalosporins. Relationship between structure, pharmacokinetics and action].
Christ W; Stein H
Med Monatsschr Pharm; 2002 Apr; 25(4):112-24; quiz 125. PubMed ID: 11980324
[No Abstract] [Full Text] [Related]
8. [Oral cephalosporins in the treatment of suppurative-inflammatory diseases].
Sidorenko SV
Antibiot Khimioter; 1996; 41(11):33-42. PubMed ID: 9214285
[No Abstract] [Full Text] [Related]
9. [Structure-activity relationships of penicillin G to tricyclic beta-lactams].
Holzgrabe U
Pharm Unserer Zeit; 2006; 35(5):410-4. PubMed ID: 17009784
[No Abstract] [Full Text] [Related]
10. [Research and development of new oral cephems, cefixime and cefdinir].
Sakane K; Kawabata K; Inamoto Y; Yamanaka H; Takaya T
Yakugaku Zasshi; 1993 Sep; 113(9):605-26. PubMed ID: 8229662
[TBL] [Abstract][Full Text] [Related]
11. AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity.
Mori N; Kodama T; Sakai A; Suzuki T; Sugihara T; Yamaguchi S; Nishijima T; Aoki A; Toriya M; Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K
Int J Antimicrob Agents; 2001 Nov; 18(5):451-61. PubMed ID: 11711261
[TBL] [Abstract][Full Text] [Related]
12. Ceftibuten--a new oral cephalosporin.
Med Lett Drugs Ther; 1996 Mar; 38(970):23-4. PubMed ID: 8598823
[No Abstract] [Full Text] [Related]
13. In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins.
Okuda J; Otsuki M; Oh T; Nishino T
J Antimicrob Chemother; 2000 Jul; 46(1):101-8. PubMed ID: 10882697
[TBL] [Abstract][Full Text] [Related]
14. Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids.
Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
J Antibiot (Tokyo); 1993 Feb; 46(2):316-30. PubMed ID: 8468248
[TBL] [Abstract][Full Text] [Related]
15. New orally active cephalosporin esters.
Yamada H; Ueda S; Mutoh M; Nagata H; Nouda H; Fukasawa M; Okuda T
J Antibiot (Tokyo); 1990 May; 43(5):578-83. PubMed ID: 2358409
[No Abstract] [Full Text] [Related]
16. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
[TBL] [Abstract][Full Text] [Related]
17. Orally absorbable D-forphenicinol-cephalosporins.
Koyama Y; Huang SP; Ikeda D; Hamada M; Kondo S; Takeuchi T
J Antibiot (Tokyo); 1989 Jun; 42(6):993-9. PubMed ID: 2737957
[TBL] [Abstract][Full Text] [Related]
18. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime.
Oszczapowicz I; Małafiej E; Szelachowska M; Horoszewicz-Małafiej A; Kuklewicz C; Sierańska E; Denys A; Niedworok J
Acta Pol Pharm; 1995; 52(5):397-401. PubMed ID: 8960273
[TBL] [Abstract][Full Text] [Related]
19. Orally active cephalosporins: synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins.
Yamamoto H; Terasawa T; Ohki A; Shirai F; Kawabata K; Sakane K; Matsumoto S; Matsumoto Y; Tawara S
Bioorg Med Chem; 2000 Jan; 8(1):43-54. PubMed ID: 10968263
[TBL] [Abstract][Full Text] [Related]
20. Studies on orally active cephalosporin esters. VI. Synthesis and antimicrobial activity of 3-(3-isoxazolyl)oxymethylcephalosporin derivatives.
Nakayama E; Watanabe K; Miyauchi M; Fujimoto K; Ide J
J Antibiot (Tokyo); 1990 Sep; 43(9):1122-30. PubMed ID: 2211375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
